The forecast for the re-import of vaccines for human use to Canada shows a steady increase from 2024, starting at 17.733 million USD. By 2028, this figure is expected to reach 18.149 million USD. This indicates a moderate growth trend, with a compounded annual growth rate (CAGR) over the five years averaging approximately 0.58%. Compared to previous years' trends, the forecast signals consistent demand stability with gradual uplift.

Future trends to watch for:

The impact of new vaccine developments and their approval rates.
The potential effects of changes in global vaccine production and distribution efficiencies.
Variations in government health policies and funding that could alter import demands.